Evidence map›Paper›PMID 29290031›Full record

ReviewMolecular biotechnology2018

Specialized Plant Metabolism Characteristics and Impact on Target Molecule Biotechnological Production.

Hélio Nitta Matsuura, Sonia Malik, Fernanda de Costa, Morteza Yousefzadi, Mohammad Hossein Mirjalili, Randolph Arroo, Avninder S Bhambra, Miroslav Strnad, Mercedes Bonfill, Arthur Germano Fett-Neto

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. EfficientInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. PlantsFrontiers in plant science · 2022
    Review
  13. Journal of advanced research · 2021
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Chemical Profile and Biological Activities of Essential Oil fromPharmaceuticals (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hélio Nitta MatsuuraPlant Physiology Laboratory, Center for Biotechnology and Department of Botany, UFRGS, Porto Alegre, RS, Brazil.
Sonia MalikHealth Sciences Graduate Program, Biological and Health Sciences Center, Federal University of Maranhão, Avenida dos Portugueses, 1966, Bacanga, São Luís, MA, 65.080-805, Brazil.
Fernanda de CostaPlant Physiology Laboratory, Center for Biotechnology and Department of Botany, UFRGS, Porto Alegre, RS, Brazil.
Morteza YousefzadiDepartment of Marine Biology, Faculty of Marine Sciences and Technology, Hormozgan University, Bandar Abbas, Iran.
Mohammad Hossein MirjaliliDepartment of Agriculture, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran.
Randolph ArrooFaculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester, LE1 9BH, UK.
Avninder S BhambraFaculty of Health and Life Sciences, De Montfort University, The Gateway, Leicester, LE1 9BH, UK.
Miroslav StrnadLaboratory of Growth Regulators, Institute of Experimental Botany AS CR, Palacký University, Šlechtitelů 11, 783 71, Olomouc, Czech Republic.
Mercedes BonfillPlant Physiology Laboratory, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain.
Arthur Germano Fett-NetoPlant Physiology Laboratory, Center for Biotechnology and Department of Botany, UFRGS, Porto Alegre, RS, Brazil. fettneto@cbiot.ufrgs.br.ORCID http://orcid.org/0000-0001-5477-2610

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 306079/2013-5Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão 2016
6 · The paper itself

Abstract

Plant secondary metabolism evolved in the context of highly organized and differentiated cells and tissues, featuring massive chemical complexity operating under tight environmental, developmental and genetic control. Biotechnological demand for natural products has been continuously increasing because of their significant value and new applications, mainly as pharmaceuticals. Aseptic production systems of plant secondary metabolites have improved considerably, constituting an attractive tool for increased, stable and large-scale supply of valuable molecules. Surprisingly, to date, only a few examples including taxol, shikonin, berberine and artemisinin have emerged as success cases of commercial production using this strategy. The present review focuses on the main characteristics of plant specialized metabolism and their implications for current strategies used to produce secondary compounds in axenic cultivation systems. The search for consonance between plant secondary metabolism unique features and various in vitro culture systems, including cell, tissue, organ, and engineered cultures, as well as heterologous expression in microbial platforms, is discussed. Data to date strongly suggest that attaining full potential of these biotechnology production strategies requires being able to take advantage of plant specialized metabolism singularities for improved target molecule yields and for bypassing inherent difficulties in its rational manipulation.

Indexed as

ArtemisininsAxenic CultureBerberineBiological ProductsBiotechnologyCell Culture TechniquesMetabolic EngineeringNaphthoquinonesPaclitaxelPhytochemicalsPlant CellsPlantsSecondary MetabolismTissue Culture TechniquesartemisininArtemisininsBerberineBiological ProductsNaphthoquinonesPaclitaxelPhytochemicalsshikoninGenetically engineered culturesIn vitro cultureNatural productsSecondary metabolitesSynthetic biology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.